Page 245 - Abstract Book KONIKA 18

Hemato-Oncology

P-HO-034
Comparison between High and Low Risk Children with Iron Deficiency Anemia
in Manado

Irene Mutiara Tandra, Max Mantik, Stefanus Gunawan
Department of Child Health, Faculty Medicine, Universitas Sam Ratulangi/Prof Dr. R. D. Kandou Hospital,
Manado, North Sulawesi, Indonesia

Abstract
Background Iron deficiency anemia is a type of anemia can be caused by a lack of intake of iron-rich foods,
such as red meat, eggs and other animal products. Ironcheq is a validated questionnaire in which there are
components related to the risk of iron deficiency anemia. Objective To find out the risk of iron deficiency
anemia in children aged 1-3 years in Manado.Methods A descriptive-cross sectional study of 115 children
aged 1-3 years in Manado from April to June 2021. This study used an ironcheq questionnaire by Sjarif,
et al. (DOI: https://doi.org/10.13181/mji.v28i1.2607).Results A total of 75 (66%) children were male and
40 (34%) were female; of which 71 (62%) children had a high risk of iron deficiency anemia with a mean
score of 5.7 based on the ironcheq questionnaire. The lowest mean score was found on the question points
regarding meat products consumption and the highest average was found in the consumption of red meat.
Conclusion Children aged 1-3 years in Manado have a high risk of iron deficiency anemia based on the
ironcheq questionnaire.
Keyword: anemia; iron deficiency; ironcheq questionnaire

P-HO-035
Anticoagulant Therapy of Budd-Chiari Syndrome: A Case Report

Erick Kristianto Adityatama, Ariawan, Bambang Sudarmanto
Departement of Childhealth, Faculty of Medicine Universitas Diponegoro Dr. Kariadi General Hospital, Semarang,
Indonesia
Abstract
Background Budd-Chiari Syndrome (BCS) is a congestive hepatopathy caused by blockage of hepatic
veins. This syndrome occured in 1/100 000 of general population. Hypercoagulable state could be identified
in 75% of the patients. Objective To demonstrate favorable response of anticoagulant therapy for BCS.
Case 2 years old boy was admitted with progressive abdominal distension. Ascites was noted. From MSCT
Angiography examination revealed hepatomegaly with inhomogenous caudatus lobe enlargement, infarct
in 5th-7th segment of the liver throughout peripheral segment, thrombus in middle hepatica vein (1.5cm x
0.4cm x 1.3cm) and left hepatic vein (0.8cm x 0.25cm x 1.15cm). Abdominal USG showed hepatomegaly
with inhomogenous parenchym, visible right hepatic vein blood-flow with unclear flow on inferior vena
cava. These findings were supporting the diagnosis of BCS. Low molecular weight heparin (LMWH) was
given. Clinically, BCS most often appears as the sudden onset of abdominal pain, ascites and hepatomegaly.
The first line therapy is anticoagulant LMWH. Anticoagulation should be immediate initiated because of
underlying thrombotic states and for a better outcome. It is often difficult to decide whether the effect of
conservative therapy with LMWH can be awaited or an invasive procedure should be done. In this case,
there was improvement in thrombotic states. D-Dimer level for this patient gradually decreased from
2519 g/L to 612 g/L and from USG Doppler evaluation there was blood flow improvement from hepatic
vein to inferior vena cava. Conclusion We concluded that anticoagulant therapy should always considered
for BCS for a better prognosis.
Keywords: BCS; anticoagulant therapy; D-dimer

KONIKA XVIII Abstract Book 197